North America Anaphylaxis Treatment Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Medication Type (Epinephrine, Antihistamines, Steroids, Beta-Agonist, and Others), Route of Administration (Oral, Parenteral, and Others), Allergy Type (Food Allergy, Medications, Insect Stings, and Others) and Distribution Channel (Hospital Pharmacies, Retail Sales, and Others)
Market Introduction
Anaphylaxis is an allergic reaction that can further lead to a fatal condition known as anaphylactic shock. Anaphylaxis occurs when the patient's body reacts to a foreign substance and produces a high amount of histamine that triggers an inflammatory response. It is a severe, life threatening allergic reaction marked by indications such as swallowing and breathing difficulties, skin itching, and lowering blood pressure.
Thus, the rising incidence of anaphylaxis is expected to create a significant demand for anaphylaxis treatment in the coming years, which is further anticipated to drive the anaphylaxis treatment market.
With the spread of the COVID-19 pandemic, it was discovered that a significant number of people around the world were suffering from chronic respiratory diseases, such as respiratory allergies, such as allergic rhinitis, and sinusitis. For instance, according to a survey conducted by the Asthma and Allergy Foundation of America in June 2020, stated that 2,695 people were made to participate in the study, out of which 57% have asthma, 51% have a family member with asthma, 63% have allergies, and 66% have a family member with allergies, within the survey group. Thus, the impact of COVID-19 is so far considered positive on the market. Allergy and asthma exacerbations are frequently triggered by viral infections, including coronaviruses. Thus, telehealth can be central in delivering allergy/immunology services within a risk-stratified context of the SARS-CoV-2 pandemic. Therefore, both the American Academy of Allergy, Asthma, & Immunology (AAAAI) and the American College of Allergy, Asthma, & Immunology (ACAAI) have been strong advocates to advance telehealth to allow allergy/immunology services to expand and most directly serve patients where they are needed. To provide an approach to triaging allergy/immunology services during the COVID-19 pandemic, a consensus-based ad-hoc expert panel of allergy/immunology specialists from the United States and Canada developed a service and patient prioritization schematic to temporarily adjust allergy/immunology services. Recommendations and feedback were developed iteratively, using an adapted, modified Delphi methodology to achieve consensus. This is likely to favor market growth.
Get more information on this report :
Market Overview and Dynamics
The Anaphylaxis treatment market in North America is expected to grow from US$ 1,635.8 million in 2021 to US$ 2,891.7 million by 2028; it is estimated to grow at a CAGR of 8.5% from 2021 to 2028. Epinephrine is the most effective treatment for anaphylaxis; however, various studies indicate underutilization of this drug due to the high cost and low availability of the drugs and unawareness regarding the drug usage and anaphylactic onset. Many organizations are developing generic drugs for the treatment of anaphylaxis. In April 2020, Amphastar Pharmaceuticals made an announcement regarding winning an FDA approved for the new drug application of its epinephrine injection, USP 30mg/30mL (1mg/mL), available in multiple dose vials. This generic drug product is known to be equivalent to Adrenalin (Endo International and Par Pharmaceutical), and it is prescribed as an emergency treatment of allergic reactions (Type 1), including anaphylaxis. However, a limited number of players are operating in this segment. The demand for epinephrine has been on the rise with limited product supply. As per the Pew Charitable Trusts, demand for epinephrine auto-injectors has increased in the last few years, and the number of EpiPen prescriptions in the US grew from ~2.5 million in 2011 to 3.5 million in 2015. The growth can be attributed to the high demand from schools.
Key Market Segments
In terms of medication type, the epinephrine segment accounted for the largest share of the North America anaphylaxis treatment market in 2020. In terms of route of administration, the parenteral segment accounted for the largest share of the North America anaphylaxis treatment market in 2020. In terms of allergy type, the food allergy segment accounted for the largest share of the North America anaphylaxis treatment market in 2020. In terms of distribution channel, the retail pharmacies segment held a larger market share of the anaphylaxis treatment market in 2020.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the anaphylaxis treatment market in North America are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Amneal Pharmaceuticals Inc., Mylan N.V., Adamis Pharmaceutical Corporation, Abbott, Pfizer Inc., Glaxosmithkline Plc., Merck and Co., Inc., Teva Pharmaceutical Industries Ltd., and ALK-ABELLó.
Reasons to buy report
- To understand the North America anaphylaxis treatment market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for North America anaphylaxis treatment market
- Efficiently plan M&A and partnership deals in North America Anaphylaxis treatment market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form North America Anaphylaxis treatment market
- Obtain market revenue forecast for market by various segments from 2021-2028 in North America region.
NORTH AMERICA ANAPHYLAXIS TREATMENT MARKET SEGMENTATION
By Medication Type
- Epinephrine
- Antihistamines
- Steroids
- Beta-Agonist
- Others
By Route of Administration
- Parenteral
- Oral
- Others
By Allergy Type
- Food Allergy
- Medications
- Insect Stings
- Others
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Others
By Country
- North America
- US
- Canada
- Mexico
Companies Mentioned
- Amneal Pharmaceuticals Inc.
- Mylan N.V.
- Adamis Pharmaceutical Corporation
- Abbott
- Pfizer Inc.
- Glaxosmithkline Plc.,
- Merck And Co., Inc.
- Teva Pharmaceutical Industries Ltd.
- ALK-ABELLó
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Anaphylaxis Treatment Market – By Medication Type
1.3.2 Anaphylaxis Treatment Market – By Route of Administration
1.3.3 Anaphylaxis Treatment Market – By Allergy Type
1.3.4 Anaphylaxis Treatment Market – By Distribution Channel
1.3.5 North America Anaphylaxis Treatment Market – By Country
2. North America Anaphylaxis Treatment Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Anaphylaxis Treatment Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Anaphylaxis Treatment Market- North America PEST Analysis
4.3 Expert Opinion
5. North America Anaphylaxis Treatment Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Incidence of Anaphylaxis
5.1.2 Recent Approvals for Epinephrine
5.2 Market Restraints
5.2.1 Poor Access to Epinephrine Auto-Injectors in Low-Income Countries
5.3 Market Opportunities
5.3.1 Rise in Cases of Allergies Post Administration of COVID-19 Vaccines
5.4 Future Trends
5.4.1 Novel Drug Delivery Systems
5.5 Impact Analysis
6. Anaphylaxis Treatment Market – North America Analysis
6.1 North America Anaphylaxis Treatment Market Revenue Forecasts and Analysis
7. North America Anaphylaxis Treatment Market Analysis and Forecasts To 2028 – By Medication Type
7.1 Overview
7.2 Anaphylaxis Treatment Market Revenue Share, by Medication Type (2020 and 2028)
7.3 Epinephrine
7.3.1 Overview
7.3.2 Epinephrine: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Antihistamines
7.4.1 Overview
7.4.2 Antihistamines: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Steroids
7.5.1 Overview
7.5.2 Steroids: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Beta-Agonist
7.6.1 Overview
7.6.2 Beta-Agonist: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Others
7.7.1 Overview
7.7.2 Others: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
8. Anaphylaxis Treatment Market Analysis – By Route of Administration
8.1 Overview
8.2 Anaphylaxis Treatment Market Revenue Share, by Route of Administration (2020 and 2028)
8.3 Oral
8.3.1 Overview
8.3.2 Oral: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Parenteral
8.4.1 Overview
8.4.2 Parenteral: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
9. North America Anaphylaxis Treatment Market Analysis and Forecasts To 2028 – By Allergy Type
9.1 Overview
9.2 Anaphylaxis Treatment Market Share, by Allergy Type, 2020 and 2028, (%)
9.3 Food Allergy
9.3.1 Overview
9.3.2 Food Allergy: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Medications
9.4.1 Overview
9.4.2 Medications: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Insect Stings
9.5.1 Overview
9.5.2 Insect Stings: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
10. North America Anaphylaxis Treatment Market Analysis and Forecasts to 2028– By Distribution Channel
10.1 Overview
10.2 Anaphylaxis Treatment Market, by Distribution Channel, 2020 and 2028 (%)
10.3 Retail Sales
10.3.1 Overview
10.3.2 Retail Sales: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Mn)
10.4 Hospital Pharmacies
10.4.1 Overview
10.4.2 Hospital Pharmacies: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Mn)
10.5 Others
10.5.1 Overview
10.5.2 Others: Anaphylaxis Treatment Market, Revenue and Forecast to 2028 (US$ Mn)
11. Anaphylaxis Treatment Market Revenue and Forecasts to 2028 – Geographical Analysis
11.1 North America: Anaphylaxis Treatment Market
11.1.1 Overview
11.1.2 North America: Anaphylaxis Treatment Market, by Country, 2020 & 2028 (%)
11.1.2.1 US: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.1.1 US: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.1.2 US: Anaphylaxis Treatment Market, by Medication Type, 2019–2028 (USD Million)
11.1.2.1.3 US: Epinephrine Treatment Market by Route of Administration, 2019–2028 (USD Million)
11.1.2.1.4 US: Others Treatment Market by Route of Administration, 2019–2028 (USD Million)
11.1.2.1.5 US: Anaphylaxis Treatment Market, by Allergy Type, 2019–2028 (USD Million)
11.1.2.1.6 US: Anaphylaxis Treatment Market, by Distribution Channel, 2019–2028 (USD Million)
11.1.2.2 Canada: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.2.1 Canada: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.2.2 Canada: Anaphylaxis Treatment Market, by Medication Type, 2019–2028 (USD Million)
11.1.2.2.3 Canada: Epinephrine Treatment Market, by Route of Administration, 2019–2028 (USD Million)
11.1.2.2.4 Canada: Others Treatment Market, by Route of Administration, 2019–2028 (USD Million)
11.1.2.2.5 Canada: Anaphylaxis Treatment Market, by Allergy Type, 2019–2028 (USD Million)
11.1.2.2.6 Canada: Anaphylaxis Treatment Market, by Distribution Channel, 2019–2028 (USD Million)
11.1.2.3 Mexico: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.3.1 Mexico: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.3.2 Mexico: Anaphylaxis Treatment Market, by Medication Type, 2019–2028 (USD Million)
11.1.2.3.3 Mexico: Anaphylaxis Treatment Market, by Route of Administration, 2019–2028 (USD Million)
11.1.2.3.4 Mexico: Anaphylaxis Treatment Market, by Route of Administration, 2019–2028 (USD Million)
11.1.2.3.5 Mexico: Anaphylaxis Treatment Market, by Allergy Type, 2019–2028 (USD Million)
11.1.2.3.6 Mexico: Anaphylaxis Treatment Market, by Distribution Channel, 2019–2028 (USD Million)
12. Impact Of COVID-19 Pandemic on North America Anaphylaxis Treatment Market
12.1 North America: Impact Assessment of COVID-19 Pandemic
13. Industry Landscape
13.1 Overview
13.2 Growth Strategies Done by the Companies in the Market, (%)
13.3 Organic Developments
13.3.1 Overview
13.4 Inorganic Developments
13.4.1 Overview
14. COMPANY PROFILES
14.1 Abbott
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Adamis Pharmaceuticals Corporation
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 ALK-Abelló A/S
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Amneal Pharmaceuticals, Inc.
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 GlaxoSmithKline plc.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Merck & Co., Inc.
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 MYLAN N.V.
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 roducts and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Pfizer Inc.
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 TEVA PHARMACEUTICAL INDUSTRIES LTD
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
15. Appendix
15.1 About the Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. US: Anaphylaxis Treatment Market, by Medication Type – Revenue and Forecast to 2028 (USD Million)
Table 2. US: Epinephrine Treatment Market by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 3. US: Others Treatment Market by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 4. US: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)
Table 5. US Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 6. Canada: Anaphylaxis Treatment Market, by Medication Type – Revenue and Forecast to 2028 (USD Million)
Table 7. Canada: Epinephrine Treatment Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 8. Canada: Others Treatment Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 9. Canada: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)
Table 10. Canada Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 11. Mexico: Anaphylaxis Treatment Market, by Medication Type – Revenue and Forecast to 2028 (USD Million)
Table 12. Mexico: Anaphylaxis Treatment Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 13. Mexico: Anaphylaxis Treatment Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 14. Mexico: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)
Table 15. Mexico Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 16. Organic Developments Done by Companies
Table 17. Inorganic Developments Done by Companies
Table 18. Glossary of Terms, Anaphylaxis Treatment Market
LIST OF FIGURES
Figure 1. Anaphylaxis Treatment Market Segmentation
Figure 2. North America Anaphylaxis Treatment Market Overview
Figure 3. Epinephrine Segment Held Largest Share of Medication Type in Anaphylaxis Treatment Market
Figure 4. US is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. Anaphylaxis Treatment Market - North America PEST Analysis
Figure 6. Anaphylaxis Treatment Market Impact Analysis of Driver and Restraints
Figure 7. North America Anaphylaxis Treatment Market – Revenue Forecasts and Analysis – 2020- 2028
Figure 8. Anaphylaxis Treatment Market Revenue Share, by Medication Type (2020 and 2028)
Figure 9. Epinephrine: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 10. Antihistamines: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. Steroids: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Beta-Agonist: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Others: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Anaphylaxis Treatment Market Revenue Share, Route of Administration (2020 and 2028)
Figure 15. Oral: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Parenteral: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Others: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Anaphylaxis Treatment Market Share, by Allergy Type, 2020 and 2028 (%)
Figure 19. Food Allergy: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Medications: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Insect Stings: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Others: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Anaphylaxis Treatment Market, by Distribution Channel, 2020 and 2028 (%)
Figure 24. Retail Sales: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Mn)
Figure 25. Hospital Pharmacies: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Mn)
Figure 26. Others: Anaphylaxis Treatment Market, Revenue and Forecast to 2028 (US$ Mn)
Figure 27. North America: Anaphylaxis Treatment Market, by Key Country – Revenue (2020) (USD Million)
Figure 28. North America: Anaphylaxis Treatment Market, by Country, 2020 & 2028 (%)
Figure 29. US: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 30. Canada: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 31. Mexico: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 32. Impact of COVID-19 Pandemic in North American Country Markets
Figure 33. Growth Strategies Done by the Companies in the Market, (%)
- Amneal Pharmaceuticals Inc.
- Mylan N.V.
- Adamis Pharmaceutical Corporation
- Abbott
- Pfizer Inc.
- Glaxosmithkline Plc.,
- Merck And Co., Inc.
- Teva Pharmaceutical Industries Ltd.
- ALK-ABELLó
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America anaphylaxis treatment market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the North America anaphylaxis treatment market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the anaphylaxis treatment market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution